Illumina, Inc. (ILMN) News
Track canonical SquawkNews coverage tagged to ILMN, Illumina, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Illumina guides FY revenue $4,600-4,640M
Illumina guides FY revenue higher
EARNINGS | Jul 30, 2026, 08:27 PM UTC
H
COHU +16.2%, AXTI +13.8%, AMZN +8.7%, MPWR +8.5%, FND +6.7%, ILMN +5%, GDYN +4.8%, CSTL +4.6%, CDNA +4.6%, EXPO +3.7%, PTCT +3.3% after resu
COHU +16.2%, AXTI +13.8%, AMZN +8.7%, MPWR +8.5%, FND +6.7%, ILMN +5%, GDYN +4.8%, CSTL +4.6%, CDNA +4.6%, EXPO +3.7%, PTCT +3.3% after results
EARNINGS | Jul 30, 2026, 08:18 PM UTC
L
Illumina Raises FY2026 Adj EPS Guidance from $5.15-$5.30 to $5.30-$5.40 vs $5.23 Est; Raises FY2026 Sales Guidance from $4.520B-$4.620B to $
Illumina (NASDAQ: ILMN ) raises FY2026 Adj EPS guidance from $5.15-$5.30 to $5.30-$5.40 vs $5.23 analyst estimate. Raises FY2026 sales outlook from $4.520 billion-$4.620 billion to $4.600 billion-$4.640 billion vs $4.566
EARNINGS | Jul 30, 2026, 08:13 PM UTC
L
ILMN Q2 adj EPS $1.31 vs. est. $1.23; Q2 revs $1.16B vs. est. $1.13B; raises FY26 adjusted EPS view to $5.30-$5.40 from $5.15-$5.30 (est. $5
ILMN Q2 adj EPS $1.31 vs. est. $1.23; Q2 revs $1.16B vs. est. $1.13B; raises FY26 adjusted EPS view to $5.30-$5.40 from $5.15-$5.30 (est. $5.23) and boosts FY26 rev view to $4.6B-$4.64B from $4.52B-$4.62B (est. $4.57B);
EARNINGS | Jul 30, 2026, 08:12 PM UTC
L
ILMN Illumina RESULTS: Q2, Q2 ebit margin 21.1%, Q2 REV $1.159B vs. EST $1.130B, Q2 ADJ gross margin 68.2%, Q2 gross margin 66.4%, Q2 ADJ eb
ILMN Illumina RESULTS: Q2, Q2 ebit margin 21.1%, Q2 REV $1.159B vs. EST $1.130B, Q2 ADJ gross margin 68.2%, Q2 gross margin 66.4%, Q2 ADJ ebit margin 22.5%, Q2 ADJ EPS $1.31 vs. EST $1.23, Illumina Earnings Notes:, - Ill
EARNINGS | Jul 30, 2026, 08:08 PM UTC
L
ILMN ILMN ILMN - Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
ILMN ILMN ILMN - Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
EARNINGS | Jul 30, 2026, 08:06 PM UTC
H
Implied EPS movers for tonight: AAPL +/-3.5%, AMZN +/-5.8%, MPWR +/-15.1%, MSTR +/-5.4%, COIN +/-6.8%, SYK +/-7.2%, RDDT +/-9.8%, DXCM +/-7.
Implied EPS movers for tonight: AAPL +/-3.5%, AMZN +/-5.8%, MPWR +/-15.1%, MSTR +/-5.4%, COIN +/-6.8%, SYK +/-7.2%, RDDT +/-9.8%, DXCM +/-7.5%, RIVN +/-7.9%, NXT +/-16.8%, MTZ +/-14.6%, AJG +/-7.2%, GH +/-14.1%, CTVA +/-
EARNINGS | Jul 30, 2026, 05:58 PM UTC
H
DHR -12% premarket after results, guidance; Peers A -3%, TMO -3%, RVTY, ILMN down about 2%
DHR -12% premarket after results, guidance; Peers A -3%, TMO -3%, RVTY, ILMN down about 2%
EARNINGS | Jul 21, 2026, 12:30 PM UTC
L
ILMN Element Biosciences Prevails in German Patent Case Against Illumina Element Biosciences Prevails in German Patent Case Against Illumina
ILMN Element Biosciences Prevails in German Patent Case Against Illumina Element Biosciences Prevails in German Patent Case Against Illumina Munich Regional Court finds Illumina infringes Element sequencing intellectual
EQUITY | Jul 14, 2026, 12:11 PM UTC
L
Illumina shares are trading higher after Piper Sandler maintained its Overweight rating on the stock and raised its price target from $170 t
Illumina shares are trading higher after Piper Sandler maintained its Overweight rating on the stock and raised its price target from $170 to $200.
EQUITY | Jul 01, 2026, 06:34 PM UTC
L
Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $200
Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ: ILMN ) with a Overweight and raises the price target from $170 to $200.
EQUITY | Jul 01, 2026, 11:52 AM UTC
M
ILMN: Bernstein Reinstates
Bernstein reinstates Illumina with a Market Perform rating and $185 price target
EQUITY | Jun 26, 2026, 01:37 PM UTC
M
ILMN Raised to $145
Illumina shares are trading higher after Barclays raised its price target on the stock from $122 to $145.
EQUITY | Jun 24, 2026, 03:19 PM UTC